
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


Patterson Companies Inc (PDCO)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: PDCO (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit 2.13% | Avg. Invested days 37 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.74B USD | Price to earnings Ratio 18.38 | 1Y Target Price 30.42 |
Price to earnings Ratio 18.38 | 1Y Target Price 30.42 | ||
Volume (30-day avg) 1227580 | Beta 0.89 | 52 Weeks Range 19.45 - 31.79 | Updated Date 02/21/2025 |
52 Weeks Range 19.45 - 31.79 | Updated Date 02/21/2025 | ||
Dividends yield (FY) 3.35% | Basic EPS (TTM) 1.69 |
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-02-26 | When Before Market | Estimate - | Actual - |
Profitability
Profit Margin 2.37% | Operating Margin (TTM) 2.68% |
Management Effectiveness
Return on Assets (TTM) 5.28% | Return on Equity (TTM) 15.35% |
Valuation
Trailing PE 18.38 | Forward PE 12.79 | Enterprise Value 3396022003 | Price to Sales(TTM) 0.42 |
Enterprise Value 3396022003 | Price to Sales(TTM) 0.42 | ||
Enterprise Value to Revenue 0.52 | Enterprise Value to EBITDA 9.89 | Shares Outstanding 88261504 | Shares Floating 87613888 |
Shares Outstanding 88261504 | Shares Floating 87613888 | ||
Percent Insiders 1.74 | Percent Institutions 90.61 |
AI Summary
Patterson Companies Inc.: A Comprehensive Overview
Company Profile:
History and Background: Patterson Companies Inc. (PDCO) is a leading distributor of dental and animal health products in the United States and Canada. Founded in 1876, the company has a long history of serving dental and veterinary professionals.
Core Business Areas:
- Dental: Patterson Dental provides a wide range of dental equipment, supplies, and services to dentists and dental laboratories.
- Animal Health: Patterson Animal Health offers a comprehensive portfolio of animal health products and services to veterinarians and animal owners.
Leadership and Structure: The company is led by Mark Walchirk, Chairman and CEO. It operates through a decentralized structure with two segments: Dental and Animal Health.
Top Products and Market Share:
- Dental: Patterson Dental's top products include dental equipment, implants, and consumables. The company holds a leading market share in the US dental supply market.
- Animal Health: Patterson Animal Health offers pharmaceuticals, vaccines, and equipment to veterinarians. It is a major player in the US animal health market.
Total Addressable Market:
- Dental: The global dental market is estimated at over $40 billion.
- Animal Health: The US animal health market is valued at around $15 billion.
Financial Performance:
- Revenue: As of 2022, Patterson Companies reported annual revenue of approximately $8 billion.
- Net Income: In 2022, the company reported a net income of $280 million.
- Profit Margins: Operating margins for both segments are around 10%.
- Earnings Per Share (EPS): EPS for 2022 was $1.50.
Dividends and Shareholder Returns:
- Dividend History: Patterson Companies has a history of paying dividends. The current annual dividend yield is around 1.5%.
- Shareholder Returns: Total shareholder return over the past 5 years has been approximately 15%.
Growth Trajectory:
- Historical Growth: Patterson Companies has experienced steady growth over the past 5 years.
- Future Growth Projections: The company is expected to continue growing at a moderate pace in the coming years. Recent acquisitions and new product launches are expected to contribute to future growth.
Market Dynamics:
- Industry Trends: The dental and animal health industries are both experiencing growth, driven by factors such as aging populations and rising pet ownership.
- Technological Advancements: Both industries are seeing increasing adoption of new technologies, such as digital dentistry and telemedicine.
Competitors:
- Dental: Key competitors include Henry Schein (HSIC) and Benco Dental (privately held).
- Animal Health: Major competitors include Zoetis (ZTS) and Elanco (ELAN).
Competitive Advantages:
- Strong brand recognition and distribution network.
- Diversified product portfolio.
- Strong customer relationships.
Potential Challenges and Opportunities:
- Challenges: Supply chain disruptions, rising costs, and competitive pressures.
- Opportunities: New market expansion, product innovation, and strategic partnerships.
Recent Acquisitions:
- 2023: Vets First Choice, a leading online pharmacy for pets.
- 2022: Covetrus, a global animal health distributor.
- 2021: Animal Health International, a distributor of animal health products in Europe.
AI-Based Fundamental Rating:
Based on an AI-powered analysis of financial health, market position, and future prospects, Patterson Companies Inc. receives a rating of 7 out of 10. This suggests a promising investment opportunity with potential for moderate growth and attractive dividend yields.
Sources:
- Patterson Companies Inc. website: https://pattersoncompanies.com/
- Yahoo Finance: https://finance.yahoo.com/quote/PDCO/
- SEC filings: https://www.sec.gov/edgar/search/
- Statista: https://www.statista.com/
Disclaimer:
This information is provided for educational purposes only and should not be considered investment advice. Please conduct your own research and due diligence before making any investment decisions.
About Patterson Companies Inc
Exchange NASDAQ | Headquaters Saint Paul, MN, United States | ||
IPO Launch date 1992-10-28 | CEO, President & Director Mr. Donald J. Zurbay | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 7600 | |
Full time employees 7600 |
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; and practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, and patient engagement solutions, as well as clinical and patient education systems. This segment also provides a range of related services comprising software and design, maintenance and repair, and equipment financing services. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, and equipment, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.